Bosnalijek begins export of Lymunix to Great Britain

SARAJevo, (Patria) - The largest Bosnian-Herzegovinian pharmaceutical company Bosnalijek has launched the export of its products to the British market. The new unique dietary supplement - Lymunix ® after starting distribution in Germany, has recently become available to customers in Great Britain. The official promotion of the start of sales of this product on the British market was held in London in mid-month.

Bosnalijek's General Director Nedim Uzunović emphasizes that Bosnalijek's entry into this market is another confirmation of the quality and potential of Bosnalijek as the largest domestic producer of pharmaceutical products and one of the regional leaders in the industry.

“This is truly a significant success for Bosnalijek in a year when the company celebrates 70 years of successful operation. Lymunix ® is a unique product, a dietary supplement that comes in the form of an oral spray and is the result of the work of exclusively our experts. This confirms the correctness of Bosnalijek's business policy, which continuously invests in its own development and its employees, while following global trends in the pharmaceutical industry,” said Uzunović.

The new product is available in the following forms: Lymunix ® – B Complex (contains vitamins B3, B5, B2, B1, B12, B6, B9, B7 and lysozyme), Lymunix ® – Iron (contains Iron (Fe) and lysozyme), Lymunix ® – Vitamin D – K2 (contains vitamins D, K2 and lysozyme), Lymunix ® – Multivitamin (contains a complex of vitamins and minerals and lysozyme), and Lymunix ® – Multivitamin Junior (contains a complex of vitamins and minerals and lysozyme, adapted for children over three years of age).

These products have a number of positive effects on the body, including maintaining the normal function of the immune and nervous systems, reducing fatigue and exhaustion, regulating hormonal activity, maintaining normal levels of red blood cells, normal heart function, normal oxygen transport in the body, normal blood clotting, maintaining bone health, teeth and muscle function, protecting cells from oxidative stress, and many others.

The uniqueness of Lymunix ® products is reflected not only in their composition but also in the fact that they are administered to the body in the form of an oral spray, which is particularly important as it ensures greater efficacy and better absorption of vitamins, minerals, and lysozyme.

Lysozyme is precisely the ingredient that provides additional value to Lymunix ® products. This enzyme, discovered by Alexander Fleming, a Nobel laureate and inventor of penicillin, is a significant factor of natural immunity that destroys bacteria, viruses, and fungi – only harmful ones, while it does not destroy so-called good bacteria – without disrupting the normal bacterial flora of the oral cavity. Lysozyme is a natural component of our body and acts against microorganisms, stimulates the immune system, and controls inflammatory responses.

Following the promotion of the new Lymunix ® product line in Great Britain, promotions will continue in other European Union countries, and sales in the Middle East are also planned. We will soon be able to buy these products on the domestic market as well, and it is important to note that Lymunix ® is also available for online purchase throughout Europe.